Medical Xpress·4 min read·hard
Researchers reveal immune mechanisms that drive development of rare allergic stomach disease
T
Tel-Aviv University
✦AI Summary
Researchers at Tel Aviv University have developed an experimental model to study eosinophilic gastritis, a rare allergic stomach disease. The study identifies immune pathways that could lead to more effective biologic therapies for patients.
Why it matters
Advancements in understanding rare diseases are critical for developing targeted treatments where options are currently limited.
edited by Lisa Lock , reviewed by Andrew Zinin
healthscience
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 95%
The article is a scientific report based on peer-reviewed research.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in